Desmopressin vs Orforglipron
Overview
Desmopressin is primarily a hormonal peptide, while Orforglipron is used for weight management & metabolic.
This page compares Desmopressin and Orforglipron across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | Orforglipron | |
|---|---|---|
| Category | Hormonal | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | Clinical trials |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | daily |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Oral administration convenience, weight loss, glucose control |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Under investigation |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while Orforglipron falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. Orforglipron: FDA-approved.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). Orforglipron is typically dosed at Clinical trials (daily).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and Orforglipron has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and Orforglipron?
- Desmopressin is primarily a hormonal peptide, while Orforglipron is used for weight management & metabolic. Desmopressin is FDA-approved for one or more indications, whereas Orforglipron is FDA-approved for one or more indications.
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is Orforglipron used for?
- Oral GLP-1.
- Can you take Desmopressin and Orforglipron together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and Orforglipron has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or Orforglipron FDA-approved?
- Desmopressin is FDA-approved for one or more indications. Orforglipron is FDA-approved for one or more indications.
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- Orforglipron — full monograph: mechanism, research, dosing & references